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Abstract
Ethnopharmacological relevance: Corydalis dubia is used in Bhutanese traditional medicine as a febrifuge
and for treating infections in the blood, liver and bile which correlate to the signs and symptoms of
malarial and microbial infections.
Aim of the study: To validate the ethnopharmacological uses of the plant and to discover potential new
therapeutic drug leads. Materials and methods C. dubia was collected from Bhutan and the alkaloids
were obtained using acid–base fractionation and separation by repeated column and preparative plate
chromatography. The alkaloids were identified from analysis of their physiochemical and spectroscopic
data and were tested for antiplasmodial, antimicrobial and cytotoxicity activities.
Results: A systematic extraction and isolation protocol yielded one new natural product, dubiamine, and
seven known isoquinoline alkaloids, scoulerine, cheilanthifoline, protopine, capnoidine, bicuculline,
corydecumbine and hydrastine. Among the four alkaloids tested, scoulerine showed the best
antiplasmodial activity with IC50 values of 5.4 μM and 3.1 μM against the antifolate sensitive and the
multidrug resistant P. falciparum strains: TM4/8.2 and K1CB1, respectively. None of the alkaloids tested
showed significant antimicrobial or cytotoxicity activities.
Conclusions: The antiplasmodial test results, of the isolated alkaloid components, are commensurated
with the ethnopharmacological uses of this plant.
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ABSTRACT
Ethnopharmacological relevance: Corydalis dubia is used in Bhutanese traditional medicine as a
febrifuge and for treating infections in the blood, liver and bile which correlate to the signs and
symptoms of malarial and microbial infections.
Aim of the study: To validate the ethnopharmacological uses of the plant and to discover potential new
therapeutic drug leads.
Materials and methods: C. dubia was collected from Bhutan and the alkaloids were obtained using
acid-base fractionation and separation by repeated column and preparative plate chromatography. The
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alkaloids were identified from analysis of their physiochemical and spectroscopic data and were tested
for antiplasmodial, antimicrobial and cytotoxicity activities.
Results: A systematic extraction and isolation protocol yielded one new natural product, dubiamine,
and seven known isoquinoline alkaloids, scoulerine, cheilanthifoline, protopine, capnoidine,
bicuculline, corydecumbine and hydrastine. Among the four alkaloids tested, scoulerine showed the
best antiplasmodial activity with IC50 values of 5.4 μM and 3.1 μM against the antifolate sensitive and
the multidrug resistant P. falciparum strains: TM4/8.2 and K1CB1, respectively. None of the alkaloids
tested showed significant antimicrobial or cytotoxicity activities.
Conclusions: The antiplasmodial test results, of the isolated alkaloid components, are commensurated
with the ethnopharmacological uses of this plant and generated a new antiplasmodial drug lead.
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1.

Introduction
Corydalis dubia Prain (Fumariaceae), which is locally known as Re-skon, is an annual yellow-

flowering glabrous herb of lower stature arising from tuberous rootstock. This plant is endemic to
Bhutan, Sikkim (India) and Chumbi Valley of Tibet (Grierson and Long, 1984). In Bhutan, it occurs in
the wild in localized parts of Lingzhi and Bumthang region at an altitude range of 4294-5039 meters
above sea level (Wangchuk et al., 2008; Anonymous, 2008). It grows sparsely with recorded density of
0.6 to 3.6 plants/m2 (Anonymous, 2008). Therapeutic uses of this plant were reported for detoxifying
impure blood, treating fever arising from the infections of liver, heart, lung, pancreas and kidney and
alleviating neuralgia and complicated disorders that have resulted from a combination of defective air,
bile and phlegm (Wangchuk et al., 2011). These are symptoms which correlate to both malarial and
microbial infections. A preliminary phytochemical screening demonstrated the presence of alkaloids
2

and that the crude MeOH and CHCl3 alkaloid extracts showed significant antiplasmodial activity
against chloroquine and antifolate resistant Plasmodium falciparum strains: TM4/8.2 and K1CB1
(Wangchuk et al., 2011). This prompted us to investigate the alkaloid constituents of C. dubia with a
view to generate potential new therapeutic agents and at the same time validate the use of this plant in
Bhutanese traditional medicine (BTM) for the treatment of malarial or microbial infections.
A systematic extraction and isolation protocol yielded one new natural product which we
named as dubiamine (1) drawn from the species name of the plant. Seven known isoquinoline alkaloids
were also isolated which were identified as scoulerine (2), cheilanthifoline (3), protopine (4),
capnoidine (5), bicuculline (6), corydecumbine (7) and hydrastine (8). Compounds 1, 2, 5 and 6 were
investigated for their antiplasmodial, antimicrobial and cytotoxicity activities. Compounds 2 showed
significant antiplasmodial activity which is reported here for the first time. The antiplasmodial
activities of compounds 3 and 4 were reported earlier by us and are included in Table 1.

2.

Materials and methods

2.1. Plant material
Wild C. dubia (whole part) was collected from Thruenchela (Altitude: 4651 m; Latitude: 27°56'
00.1''; Longitude: 89° 26' 11.6''; global positioning system (GPS) point number: 167; Site number:
P167; Slope: 30°; Aspect: North-West), under the Lingzhi region in Bhutan in August 2009. The
herbarium voucher specimen with accession number 78 was authenticated by Samten, a
pharmacognosist at the Pharmaceutical and Research Unit (PRU) and was deposited at the herbarium
unit of PRU, Thimphu, Bhutan.

2.2.

Extraction, isolation and identification of alkaloids
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The extraction and separation of the alkaloids from the crude methanol extract (65.12 g obtained
from 2 kg dry plant material) was undertaken via an acid/base extraction procedure using the analytical
chemicals and tools as reported in Wangchuk et al. (2012). This protocol furnished the CH2Cl2 extract
(17.87 g) which contained a mixture of acidic and neutral compounds and the CHCl3 extract (1.13 g)
which contained the basic alkaloids. Focusing on the alkaloids, the CHCl3 extract (1.2 g) was
chromatographed on a silica gel (120 g, 200-300 mesh) column, eluting with a gradient solvent system
of MeOH-CHCl3 (total combined volume of 200 mL in a v/v ratio of 0:100, 0.5:99.5, 1.5:98.5, 3:97,
4:96, 5:95, 7:93, 10:90, 15:85, 20:80, 30:70, 40:60) to obtain fractions F1-F11. Fraction F4, upon
crystallization from CHCl3/MeOH (1:1), yielded compound 5 (80 mg). Its mother liquor was purified
by column chromatography eluting with a gradient solvent system of MeOH-CHCl3 to obtain five subfractions F4.1-F4.5. The separation of these sub-fractions F4.2, F4.3, F4.4 and F4.5 using preparative
TLC plates (mobile phase; CHCl3/ethyl acetate/NH4OH) (55:45:4 drops) yielded compounds 3 (15
mg), 6 (18 mg), 7 (5 mg), and 8 (0.7 mg). Fractions 5 and 6 were combined (F56) and then separated
by the column chromatography with a gradient solvent system of ethyl acetate-CHCl3 (50 mL, v/v ratio
of 0:100, 20:80, 40:60, 50:50, 60:40, 80:20, 100:0) to obtain sub-fractions F56.1-F56.6. Further
separation of sub-fraction F56.2 on preparative TLC plates (mobile phase; CHCl3/ethyl acetate (55:45))
gave compound 2 (9 mg). Crystallization of the sub-fraction F56.3 from CHCl3/MeOH (1:1) furnished
compound 1 (7 mg). Fraction F7 was crystallized from the ethyl acetate/hexane (1:1) to give compound
4 (160 mg), the major alkaloid of the plant.
Compound 1 was identified as a new natural product which we named as dubiamine after the
name of the plant species. It was obtained as colorless needle-like crystals with mp 192.8-194.6 °C;
ESI-MS (m/z) 300 [M + H+]; EI-MS (m/z): 299 [M+•], 298, 192, 176, 164, 148 (100%), 134, 121, 107;
and HR-ESI-MS (m/z) 300.1597 [M + H]+ (300.1600 calc. for C18H22NO3). 1H-NMR (500 MHz,
CDCl3): δ 2.73 (2H, t, J = 5.8 Hz, H-3), 2.81 (2H, t, J = 5.8 Hz, H-4), 3.53 (2H, s, H-1), 3.60 (2H, s,
4

H-2), 3.80 (3H, s, OMe on C-7), 3.83 (3H, s, OMe on C-6), 6.48 (1H, s, H-8), 6.58 (1H, s, H-5), 6.75
(2H, d, J = 8.0 Hz, H-3' and H-5'), 7.22 (2H, d, J = 7.5 Hz, H-2' and H-6').
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C-NMR (125 MHz,

CDCl3): δ 28.7 (C-4), 50.7 (C-3), 55.6 (C-1), 56.0 (OMe), 56.1 (OMe), 62.2 (C-2), 109.7 (C-8), 111.6
(C-5), 115.3 (C-3' and C-5'), 126.3 (C-8a), 126.7 (C-4a), 130.1 (C-1'), 130.7 (C-2' and C-6'), 147.6 (C-6
and C-7).
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Fig. 1. Alkaloids isolated from Corydalis dubia.
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Fig. 2. Single crystal structure of dubiamine (1) with CCDC 872799.

The structure of 1 (Fig. 1) was confirmed from the analysis of its single crystal X-ray
crystallographic data (Fig. 2): (C18H21NO3), Mr 299.37. Monoclinic, P21/n, a = 6.4140 (1) Å, b =
13.0324 (3) Å, c = 19.2120 (4) Å, β = 98.8791 (11)°, V = 1586.68 (6) Å3, Z = 4, F (000) = 640, Dx =
1.253 Mg m–3, MoKα radiation, λ = 0.71073 Å, cell parameters from 26826 reflections, θ = 26-27.5°, μ
= 0.09 mm–1, specimen = 0.42 × 0.35 × 0.22 mm (colorless block). 46844 reflections were measured to
2max = 55° and merged to 3625 unique reflections. Final R(3174 reflns with F2 > 2(F2)) = 0.037, wR
(all data) = 0.101, S = 0.99.
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and allocated
the deposition number CCDC 872799.
While 1 has not been reported as a natural product, it has been synthesized in vitro from the
enzymatic oxidation of d,l-N-norarmepavine which was assigned the IUPAC name as 4-((6,7dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)phenol (Inubushi et al., 1969). This alkaloid was
closely related to sendaverine and its derivatives (Pandey and Tiwari, 1980; Kametani and Ohkubo,
1965; Suau et al., 1994). Other known compounds 2-8 were identified through MS library matching
techniques (NIST08s) and subsequent comparison of their melting point, optical rotation, mass spectra
and NMR spectra (1H and
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C) with those reported. Compound 2 was identified as scoulerine

(Brochman-Hanssen and Nielson 1966; Cheng et al., 2008), compound 3 as cheilanthifoline (Okamoto
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et al., 1971; Haisova and Slavik, 1973; Yeola and Mali, 1984; Rucker et al., 1994; Cheng et al., 2008),
compound 4 as protopine (Abou-Donia et al., 1980; Takahashi et al., 1985; Seger et al., 2004),
compound 5 as capnoidine (Blasko et al., 1982; Ribar and Meszaros, 1991; Pilar et al., 2010) whose
structure was also confirmed from a X-ray crystal structure (not shown here), compound 6 as
bicuculline (Edwards and Handa, 1961; Abou-Donia et al., 1980; Blasko et al., 1982; Elango, et al.,
1982; Basha et al., 2002), compound 7 as corydecumbine (Basnet et al., 1993) and compound 8 as
hydrastine (Blasko et al., 1982; Elango, et al., 1982).

2.3.

Bioassay methods
Antiplasmodial, antimicrobial and cytotoxicity bioassays were carried out using the standard

protocols reported by Wangchuk et al., (2011). The test strains of Plasmodium falciparum used for the
antiplasmodial assay were K1CB1, a multidrug resistant strain; and TM4/8.2, a wild type chloroquine
and antifolate sensitive strain. Chloroquine, cycloguanil and pyrimethamine were used as reference
drugs or positive controls in the antiplasmodial assays. DMSO (0.1%) and distilled water were used as
controls to rule out the solvent effects on the bioassay results of the test samples. All the experiments
were performed three times in duplicate (3x2).

3.

Results and Discussions
Given the traditional use of C. dubia to treat fever and various disorders bearing relevance to

malaria and microbial infections and the evidence that the crude alkaloid extracts exhibited significant
antiplasmodial activity (Wangchuk et al., 2011), we investigated the bioactive alkaloid constituents of
this plant. Out of eight alkaloids (compounds 1-8, Fig. 1) isolated from this plant, we examined
compounds 1, 2, 5 and 6 for their antiplasmodial, cytotoxicity and antimicrobial and activities (Table
1).
8

Table 1
Antiplasmodial activity (IC50 in μg/mL) of the pure compounds 1, 2, 5 and 6 isolated from C. dubia.
Antiplasmodial

Samples

Cytotoxicity

TM4/8.2

K1CB1

Vero cells

MeOH extract

6.38 ± 0.62a

9.50 ± 0.84a

>10 a

CHCl3 alkaloid extract

2.21 ± 0.43 a

2.84 ± 0.32 a

>10 a

Dubiamine (1)

>20

>20

>20

Scoulerine (2)

1.78 ± 0.72

1.04 ± 0.08

>20

0.90 ± 0.27b

1.22 ± 0.84b

Not tested

c

c

>3.5c

Cheilanthifoline (3)
Protopine (4)

1.45 ± 0.53

1.38 ± 0.31

Capnoidine (5)

>20

>20

>20

Bicuculline (6)

>10

>10

>10

d

0.010

0.089

d

Cycloguanil

0.009

0.810

Pyrimethamined

0.020

7.700

Chloroquine

Ellipticinee
Doxorubicine

a

original
activity
>10 a taken from
Wangchuk
>10 a
et al. (2011).
>20 b
original
>20
activity
Not tested
taken from
>3.5c
Wangchuk
>20
et al. (2010).
>10 c
original
KB cells

activity
taken

from

Wangchuk

0.093
0.56

et al. (2012).
d

Reference

drugs for antiplasmodial activity.
e

Reference drugs for cytotoxicity activity.

Interestingly, compound 2 demonstrated significant in vitro antiplasmodial activity against the
P. falciparum strains: TM4/8.2 (a wild type chloroquine and antifolate sensitive strain) and K1CB1
(multidrug resistant strain) with IC50 values of 1.78 µg/mL (5.47 μM) and 1.04 µg/mL (3.1 μM),
respectively. Compounds 3 and 4 were isolated from different plant species and their antiplasmodial
activities were determined earlier by us (Wangchuk et al., 2010; Wangchuk et al., 2012) and are
included in this study (Table 1). Compounds 2, 3, and 4 exhibited similar antiplasmodial activity.
However, the activities of compound 2 were found to be almost two fold better than the CHCl3 crude
alkaloid extract (2.21 and 2.84 µg/mL against TM4/8.2 and K1CB1 strains, respectively); seven fold
9

better than the crude MeOH extract (6.38 µg/mL for TM4/8.2 and 9.50 µg/mL for K1CB1 strains); and
eight fold better than the conventional antimalarial drug pyrimethamine (reference drug) against the
K1CB1 strain (Table 1). Although the antiplasmodial activity of scoulerine (2) does not meet the
criteria of the medicines for malaria venture (MMV), it represents a potential new scaffold based on
which the improved antimalarial lead compounds can be drawn, particularly as it did not show
mammalian cell line (KB and Vero cells) toxicity (Table 1) and has not been previously reported.
Scoulerine has been reported to exhibit other activities such as: anti-topoisomerase I (Cheng et al.,
2008), GABAA receptor agonist (Eisenreich et al., 2003), and antiemetic, antitussive and antibacterial
activities (Taylor and Francis, 2011).
Compounds 1, 5 and 6 did not show antiplasmodial activity even at the highest tested
concentration of 10-20 μM. Due to the smaller quantities of compounds 7 and 8, their biological
activity studies were not carried out.
Since compounds 2, 3 and 4 have shown significant antiplasmodial activities and that protopine
(4) was the major alkaloid present, it may be deduced that these three alkaloids (alone or
synergistically) may be responsible for the significant activity of the CHCl3 crude alkaloid extract of
this plant. The antimicrobial assay of the pure alkaloids (1-6) did not identify any compounds with
significant activity against Escherrichia coli, Staphylococcus aureus, Staphylococcus epidermidis,
MRSA, Bacillus subtilis, Vibrio cholera and Candida albicans with all showing MIC values greater
than 250 μg/mL.
The significant antiplasmodial activities of the crude extracts and the isolated three pure
compounds 2, 3 and 4 provide support for the use of C. dubia in BTM for treating fever associated with
malaria and other infections of the blood, liver and bile. Thus, our study verified the ethnomalarial uses
of the plant.
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4.

Conclusions and future directions
In summary, our study found the following: a) a new natural product (1) was isolated which we

named as dubiamine and its structure was confirmed from its single crystal X-ray structure

b)

compound 2 showed significant in vitro antiplasmodial activity without mammalian cell toxicity and
was identified as a potential antimalarial hit scaffold c) the in vitro antiplasmodial activity of the crude
extracts and the pure compounds 2, 3 and 4 is commensurated with the ethnopharmacological uses of
this plant and thus substantiated its usage in BTM for the aforementioned disorders. However, it may
be premature to claim that the plant extract formulated and administrated according to traditional
protocols would be safe and effective for treating humans. Therefore, in vivo animal model of malaria
using methods of traditional preparation and administration would more confidently support the use of
the plants in treating humans. As resistance to the front line antimalarial drug, artesunate, appears to be
emerging (Dondorp et al., 2009), the above in vivo experiments on crude extracts and also on
compound 2, 3 and 4 which showed significant antiplasmodial activity against antifolate sensitive and
multidrug resistant strains are essential and will be possibly carried out in future.
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